drug screening | TargetMol

カタログ番号	製品名	ターゲット
T21980	PD 198306	MEK
	PD 198306 is a selective inhibitor of MAPK/ERK-kinase (MEK) with antihyperalgesic effects. PD 198306 reduces the Streptozocin-induced increase in the level of active ERK1.
T67752	Compound V007-6018	Others
	Compound V007-6018 is a pharmaceutical compound used for drug screening.
T78520	CYT296	Others
	CYT296 is a chromatin de-condensation agent that enhances the efficiency of induced pluripotent stem cell (iPSC) generation mediated by defined factors (OSKM) and promotes an open chromatin state in Mouse Embryonic Fibro...
T36695	TAS-103
	TAS-103 is a dual inhibitor of DNA topoisomerase I/II, used for cancer research. TAS-103 is a dual inhibitor of DNA topoisomerase I/II. TAS-103 (0.1-10 μM) is active on CCRF-CEM cells, with an IC50 value of 5 nM. TAS-103...

カタログ番号	製品名	別名	ターゲット
T17143	Toyocamycin	Vengicide	Apoptosis , Others , IRE1 , Antibiotic , Antifungal
	Toyocamycin (Vengicide) is an adenosine analog produced by Actinomycete, acts as an XBP1 inhibitor, inhibits IRE1α-induced ATP-dependent XBP1 mRNA cleavage (IC50: 80 nM). Toyocamycin induces apoptosis.
T4S0051	Coptisine sulfate		Indoleamine 2,3-Dioxygenase (IDO)
	1. Coptisine sulfate has growth inhibitory activity against human cancer cell line in the NCI's anticancer drug screening program.

カタログ番号	製品名
L1000	Approved Drug Library	2808 compounds
	A unique collection of 2808 approved drugs for high throughput screening (HTS) and high content screening (HCS);
L5600	Mini Scaffold Library	5000 compounds
	Diversity: Selected from 1,600,000 drug-like compounds covering rich chemical scaffolds, 5000 compounds representing 5000 scaffolds；
L4200	FDA-Approved Drug Library	1729 compounds
	A unique collection of 1729 FDA approved drugs for high throughput screening (HTS) and high content screening (HCS);
L9100	Phosphatase Inhibitor Library	79 compounds
	A collection of 79 phosphatase inhibitors with known activity;
L5800	Drug Metabolite/Impurity Library	197 compounds
	A unique collection of 197 drug isomers/metabolites for high throughput screening (HTS) and high content screening (HCS);
L3400	Clinical Compound Library	3404 compounds
	A unique collection of 3404 compounds in clinical trial phases for high throughput screening (HTS) and high content screening (HCS);
L4500	Anti-Fungal Compound Library	252 compounds
	A unique collection of 252 antifungal compounds effective for drug repurposing screening, combination screening and biological investigation.
L9200	Drug Repurposing Compound Library	4541 compounds
	A unique collection of 4541 approved and clinical drugs for high throughput screening (HTS) and high content screening (HCS);
L5610	Golden Scaffold Library	10000 compounds
	Diversity: Selected from 1,600,000 drug-like compounds, 10000compounds representing 5000 scaffolds selected from a large drug-like chemical source；
L6100	Polyphenolic Natural Product Library	635 compounds
	A unique collection of 635 natural polyphenolic compounds for high throughput screening (HTS) and high content screening (HCS);
L1710	Anti-COVID-19 Compound Library	1133 compounds
	A unique collection of 1133 compounds with confirmed anti-SARS-CoV-2 activity or potential activity and part of them are broad-spectrum antiviral agents；
L4000	Bioactive Compound Library	14439 compounds
	A collection of 14439 small molecule compounds with validated activity for high throughput screening (HTS), high content screening (HCS), cell induction, and target identification;
L7820	High Solubility Micro Fragment Library	1081 compounds
	The compound library of highly soluble micro-fragments consists of 1081 low-molecular-weight fragments.
L8800	Drug-Fragment Library	1119 compounds
	1119 drug fragments，a must-have tool for FBDD;
L6010	Natural Product Library	3840 compounds
	A unique collection of 3840 natural products for high throughput screening (HTS) and high content screening (HCS);
L5200	Anti-Metabolism Disease Compound Library	1544 compounds
	A unique collection of 1544 metabolism diseases related compounds for high throughput screening (HTS) and high content screening (HCS);
L9230	ReFRAME Related Library	3210 compounds
	A unique collection of 3210 compounds for high-throughput screening and high-content screening,
L2200	Tyrosine Kinase Inhibitor Library	1016 compounds
	A unique collection of 1016 tyrosine kinase inhibitors for high throughput screening and high content screening for drug discovery in tyrosine kinase related diseases;
L8000	Stem Cell Differentiation Compound Library	1197 compounds
	A unique collection of 1197 stem cell differentiation signaling targeted compounds for high throughput and high content screening;
L6600	Anti-Gastroenteritis Natural Product Library	219 compounds
	A unique collection of 219 natural products related to gastroenteritis for high throughput screening (HTS) and high content screening (HCS);
L8100	Cell Cycle Compound Library	677 compounds
	A unique collection of 677 cell cycle related compounds for high throughput screening (HTS) and high content screening (HCS);
L1010	FDA-Approved & Pharmacopeia Drug Library	3158 compounds
	3158 compounds from marketed drugs for high throughput screening (HTS) and high content screening (HCS);
L2300	Ion Channel Inhibitor Library	931 compounds
	A unique collection of 931 compounds targeting ion channels for research in ion channels-related diseases and ion channel drug discovery;
L6030	Natural Product Derivatives Library for CADD	163000 compounds
	Large quantity: contains 163,000 natural product derivatives and the number is continuously updating;
L2150	Anti-Cancer Drug Library	3080 compounds
	A unique collection of 3080 anticancer drugs for high throughput screening (HTS) and high content screening (HCS);
LF1000	Pre-plated Diversity Sets	50000 compounds
	For your convenience, there are Diversity Sets of 5,000, 10,000, 15,000, and 20,000 compounds with no structure overlap.
L9500	Target-Focused Phenotypic Screening Library	1796 compounds
	A unique collection of 1796 annotated bioactive compounds with clear targets, suitable for phenotypic screening；
L5500	Toxic Compound Library	262 compounds
	A unique collection of 262 toxic substances for high throughput screening (HTS) and high content screening (HCS);
L4510	Anti-Parasitic Compound Library	419 compounds
	419 well-chosen unique anti-parasitic small molecules;
L1800	Anti-Infection Compound Library	2938 compounds
	A unique collection of 2938 anti-infective compounds including anti-bacterial, anti-fungi, anti-Human Cytomegalovirus (HCMV), anti-HIV, anti-SARS, anti-influenza, etc;
L9850	Orally Active Compound Library	2427 compounds
	A unique collection of 2427 of orally active compounds for high-throughput screening and high-content screening.
L4600	Selected Plant-Sourced Compound Library	3048 compounds
	A unique collection of 3048 plant-sourced compounds that derived from 277 plant species for high throughput screening (HTS) and high content screening (HCS);
L6700	Anti-Tumor Natural Product Library	1772 compounds
	A unique collection of 1772 natural products with known anti-cancer activity for high throughput screening (HTS) and high content screening (HCS);
L3600	Cytokine Inhibitor Library	604 compounds
	A unique collection of 604 compounds targeting cytokine signaling for high throughput screening and high content screening for drug discovery;
L1600	Kinase Inhibitor Library	2720 compounds
	A unique collection of 2720 kinase inhibitors/regulators for high throughput screening and high content screening for drug discovery in kinase related diseases;
L6610	Anti-infective Natural Product Library	1060 compounds
	A unique collection of 1060 species of natural products with anti-infective activity for high throughput screening (HTS) and high content screening (HCS);
L4400	Antibiotics Library	692 compounds
	A unique collection of 692 compounds with antibiotic activity for new antibacterial drug screening;
L5900	CNS-Penetrant Compound Library	509 compounds
	A unique collection of 509 CNS-Penetrant compounds for high throughput screening (HTS) and high content screening (HCS);
L2800	Serotonin Receptor-Targeted Compound Library	268 compounds
	A unique collection of 268 compounds targeting serotonin receptors for high throughput screening and high content screening;
L1500	GPCR Compound Library	1940 compounds
	A unique collection of 1940 GPCR-active agents for high throughput screening and high content screening for GPCR drug discovery, and new GPCR target identification and research;
L3500	Histone Modification Compound Library	469 compounds
	A unique collection of 469 histone modification related compounds for high throughput screening (HTS) and high content screening (HCS);
L4020	NO PAINS Compound Library	9384 compounds

L2610	Neurotransmitter Receptor Compound Library	1513 compounds
	A unique collection of 1513 neurotransmitter receptor compounds, can be used for HTS and HCS screening；
L4100	TGF-beta/Smad Compound Library	184 compounds
	A unique collection of 184 TGF-beta/Smad signaling targeted compounds for high throughput and high content screening;
L9210	Pediatric Drug Library	972 compounds
	A unique collection of 972 pediatric drugs for high-throughput screening and high-content screening.
L3700	JAK-STAT Compound Library	252 compounds
	A unique collection of 252 JAK/STAT signaling targeted compounds for high throughput and high content screening;
L1700	Anti-Viral Compound Library	1040 compounds
	A unique collection of 1040 anti-virus compounds effective for new anti-virus drugs high throughput screening and high content screening;
L2160	Anti-Cancer Active Compound Library	3188 compounds
	A unique collection of 3188 compounds with known anti-cancer activity for high throughput screening (HTS) and high content screening (HCS);
L1510	Nuclear Receptor Compound Library	531 compounds
	A unique collection of 531 nuclear receptor signaling targeted compounds for high throughput and high content screening;
L2500	Human Endogenous Metabolite Library	499 compounds
	A collection of 499 selected human endogenous metabolites for high throughput and high content screening.
L1900	Anti-Diabetic Compound Library	683 compounds
	A unique collection of 683 diabetes related compounds;
L6900	Rare Natural Product Library	693 compounds
	A unique collection of 693 rare natural products, which can be used for high throughput screening (HTS) and high content screening (HCS);
L2100	Anti-Cancer Compound Library	7234 compounds
	A unique collection of 7234 compounds with anti-cancer activity for high throughput screening (HTS) and high content screening (HCS);
L3100	Hematopoietic Toxicity Compound Library	101 compounds
	A unique collection of 101 compounds with defined hematopoietic toxicity for high throughput and high content drug screening;
L6160	RO5 Drug-like Natural Product Library	2703 compounds
	A unique collection of 2703 natural product monomers that meet the "Lipinski's Rule of Five", a powerful tool for HTS and HCS screening;
L5510	Drug-induced Liver Injury (DILI) Compound Library	1001 compounds
	A unique collection of 1001 hepatotoxicity causing compounds, a powerful tool for drug toxicity study, can be used for HTS and HCS screening；
L8200	Anti-Aging Compound Library	3279 compounds
	A unique collection of 3279 anti-aging compounds for high throughput screening (HTS) and high content screening (HCS);
L4010	Bioactive Compounds Library Max	22555 compounds
	A collection of 22555 bioactive compounds for high-throughput screening, high-content screening, cell induction and target identification.
L2570	Human Metabolite Library	4454 compounds
	A unique collection of 4454 human metabolites for high-throughput, high-content screening.
L1400	MAPK Inhibitor Library	365 compounds
	A unique collection of 365 compounds targeting MAPK signaling for drug discovery in MAPK related diseases;
L4300	Wnt/Hedgehog/Notch Compound Library	237 compounds
	A unique collection of 237 Wnt/Hedgehog/Notch signaling targeted compounds for high throughput and high content screening;
L6300	Food as Medicine Compound Library	1290 compounds
	A unique collection of 1290 compounds from food as medicine for high throughput and high content screening;
L2130	Anti-Cancer Metabolism Compound Library	1268 compounds
	A unique collection of 1268 cancer cellular metabolism related compounds for cancer research and high throughput screening (HTS) and high content screening (HCS);
L1100	Protease Inhibitor Library	343 compounds
	A unique collection of 343 protease and proteasome inhibitors for research in chemical genomics, and drug screening;
L2501	Human Endogenous Metabolite Compound Library Plus	1283 compounds

L6020	Selectable Natural Product Library	16627 compounds
	A unique collection of 16627 pure natural products with diverse structures and sources covering various plant, animal, and microbe species;
L6230	Miao medicine Compound Library	534 compounds
	A unique collection of 534 compounds featuring natural product molecules derived from Miao medicine that can be used for high-throughput and high-content screening.
L5700	Featured Fragment Library	246 compounds
	A unique collection of 246 fragment-like small molecules for FBDD;
L2180	Anti-Cancer Compound Library Plus	1468 compounds
	Well-chosen 1468 anti-tumor compounds with unique structures;
L2151	Chemotherapy Drug Library	48 compounds
	48 Chemotherapeutic drugs that can be used for high-throughput and high-content screening.
L7900	Osteogenesis Compound Library	317 compounds
	A unique collection of 317 osteogenesis related compounds for high throughput and high content screening;
L2140	Cancer Cell Differentiation Compound Library	406 compounds
	A unique collection of 406 cancer cell differentiation inducing compounds for high throughput and high content screening;
L1300	PI3K-AKT-mTOR Compound Library	420 compounds
	A unique collection of 420 compounds targeting PI3K/Akt/mTOR signaling for research in PI3K/Akt/mTOR signaling, and drug discovery in diseases involved with PI3K/Akt/mTOR signaling;
L4710	Nonsteroidal Anti-Inflammatory Compound Library	530 compounds
	530 non-steroidal anti-inflammatory compounds for high-throughput and high-content screening.
L6620	Antiparasitic Natural Product Library	253 compounds
	A unique collection of 253 natural products with antiparasitic activity, a powerful tool for high throughput screening (HTS) and high content screening (HCS);
L6110	Alkaloid Natural Product Library	464 compounds
	A unique collection of 464 natural alkaloids can be used for high throughput and high content screening；
L2510	Lipid Metabolism Compound Library	492 compounds
	A unique collection of 492 compounds targeting lipid metabolism, can be used for high-throughput screening (HTS) and high-content screening (HCS).
L6220	Traditional Mongolian Medicine Compound Library	950 compounds
	A collection of 950 natural product molecules originated from Mongolian medicine, which can be used for high-throughput and high-content screening.
L7600	Chemokine Inhibitor Library	59 compounds
	A unique collection of 59 chemokines or chemokine receptors targeted compounds for high throughput and high content screening;
L4800	Angiogenesis related Compound Library	1353 compounds
	A unique collection of 1353 proangiogenic and antiangiogenic compounds for new targets identification, research in mechanisms of angiogenesis, and high throughput screening (HTS) and high content screening (HCS);
L2195	Anti-Prostate Cancer Compound Library	2070 compounds
	2070 compounds associated with prostate cancer that can be used for high-throughput and high-content screening.
L6800	Chinese Pharmacopoeia Natural Product Library	2051 compounds
	A unique collection of 2051 natural products included in Chinese Pharmacopoeia (CP), a powerful tool for drug development and pharmacological study;
L6500	Microbial Natural Product Library	550 compounds
	A unique collection of 550 microbial natural products for high throughput screening (HTS) and high content screening (HCS);
L7500	Coagulation and Anticoagulation Compound Library	144 compounds
	A unique collection of 144 procoagulation and anticoagulation related compounds for high throughput screening (HTS) and high content screening (HCS);
L1610	FDA-Approved Kinase Inhibitor Library	263 compounds
	A unique collection of 263 kinase inhibitors/regulators for specific targeting of kinases, ready for high-throughput screening and high-content screening.
L2152	Targeted Therapy Drug Library	119 compounds
	119 tumor-targeted drugs that can be used for high-throughput and high-content screening.
L6210	Tibetan medicine Compound Library	747 compounds
	A collection of 747 natural product molecules originated from Tibetan medicine, which can be used for high-throughput and high-content screening.
L9610	Cyclic Peptide Library	55 compounds
	55 species of cyclic peptide molecules for high-throughput and high-content screening;
L2521	Glycolysis Compound Library	555 compounds
	555 glycolysis-related active compounds for high-throughput and high-content screening.
L6400	Marine Natural Product Library	144 compounds
	A unique collection of 144 marine natural products for high throughput screening (HTS) and high content screening (HCS);
L5100	Fluorochemical Library	574 compounds
	A unique collection of 574 fluorochemicals that can be used for high through-put screening (HTS) and high content screening (HCS);
L4700	Immunology/Inflammation Compound Library	4720 compounds
	A unique collection of 4720 anti-inflammation compounds effective for high throughput screening and high content screening.
L6150	Covalent Natural Product Library	583 compounds
	Detialed biological information and pharmacological information of the products, providing theoretical direction and research basis for screening.
L9300	Macrocyclic Compound Library	210 compounds
	210 macrocyclic compounds of known activity for high-throughput, high-content screening;
L9400	PPI Inhibitor Library	485 compounds
	A unique collection of 485 PPI-related compounds for drug screening;
L8110	Reprogramming Compound Library	1813 compounds
	A unique collection of 1813 reprogramming signaling pathway-related bioactive small molecule compounds for high-throughput, high-content screening.
L7110	Anti-Hypertension Compound Library	678 compounds
	678 hypertension-related small molecules for high-throughput and high-content screening.
L6820	Tobacco Monomer Library	747 compounds

L2194	Anti-Colorectal Cancer Compound Library	1545 compounds
	1545 compounds associated with colorectal cancer that can be used for high-throughput and high-content screening.
L2170	Immuno-Oncology Compound Library	449 compounds
	A unique collection of 449 compounds acting on immune-oncology therapeutic targets can be used for high throughput and high content screening；
L6200	The Yao nationality medicine Library	221 compounds
	A collection of 221 natural product molecules originated from Yao medicine, which can be used for high-throughput and high-content screening.
L7100	Anti-Obesity Compound Library	2247 compounds
	A unique collection of 2247 anti-obesity compounds for high throughput and high content screening;
L9000	Apoptosis Compound Library	1760 compounds
	A unique collection of 1760 apoptosis-related compounds for apoptosis research, research in tumorigenesis, and anti-cancer drug screening;
L2550	Glutamine Metabolism Compound Library	565 compounds
	A unique collection of 565 glutamine metabolism related compounds can be used for high throughput screening (HTS) and high content screening (HCS), and also is an effective tool for research in glutamine metabolism and ...
L6720	Anti-COVID-19 Traditional Chinese Medicine Compound Library	1147 compounds
	A unique collection of 1147 monomers from 60 TCM plants, a powerful tool for anti-COVID-19 drug discovery, can be used for HTS and HCS screening；